Medication of hydroxychloroquine, remdesivir and convalescent plasma during the COVID-19 pandemic in Germany : an ethical analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Environmental Research and Public Health ; 18 (2021), 11. - Art.-Nr. 5685. - eISSN 1660-4601
- Schlagwort
-
COVID-19
Arzneimittel
Medizinethik
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2021
- Urheber
- DOI
-
10.18725/OPARU-39675
- URN
-
urn:nbn:de:bsz:289-oparu-39751-3
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Voit, Katja
- Timmermann, Cristian
- Steger, Florian
- Universität Ulm
Entstanden
- 2021
Ähnliche Objekte (12)
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
The Convalescent
The convalescent
Solubility measurement and modeling of hydroxychloroquine sulfate (antimalarial medication) in supercritical carbon dioxide
The illustrious convalescent
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
"The convalescent" in France
The Liverpool convalescent institution.
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
The Convalescent
The convalescent
Solubility measurement and modeling of hydroxychloroquine sulfate (antimalarial medication) in supercritical carbon dioxide
The illustrious convalescent
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
"The convalescent" in France
The Liverpool convalescent institution.
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
The Convalescent
The convalescent
Solubility measurement and modeling of hydroxychloroquine sulfate (antimalarial medication) in supercritical carbon dioxide
The illustrious convalescent
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
"The convalescent" in France
The Liverpool convalescent institution.
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir